Abstract
The key role of neuroimaging in brain disorders is to assist clinical management by either making a precise diagnosis or providing clinically relevant differential diagnoses. There is a marked diversity of neuropathologies spanning a constellation of conditions including vascular, infectious-inflammatory, degenerative and neoplastic entities, and the clinical presentations can often be quite nonspecific, hence the key role of neuroimaging is formulating a management plan. Cranial ultrasonography (US), Computed Tomography (CT) and Magnetic Resonance (MR) are the currently available modalities of neuroimaging, each with its specific strengths and limitations. Overall, MR Imaging (MRI) is the most useful technique to study the brain, given its higher soft tissue contrast, although CT has a central role still in acute imaging and is also the best technique to investigate for associated bony disorders. Cranial US has a vital role in foetal and neonatal imaging given its bedside ease and the presence of a good acoustic window—the skull foramina in this population. This chapter focuses on those clinical applications of neuroimaging that complement the practice of nuclear medicine with special relevance to CT and MRI.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ACR-ASNR. ACR-ASNR practice guideline for the performance of computed tomography (CT) of the brain. Oak Brook, IL: ACR-ASNR; 2010.
Ellingson BM, Bendszus M, et al. Consensus recommendations for a standardized brain tumor imaging protocol in clinical trial. Neuro Oncol. 2015;17:1188–98.
Welker K, Boxerman J, et al. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. Am J Neurorad. 2015;36:E41–51.
ACR-ASNR. ACR/ASNR practice guideline for the performance and interpretation of magnetic resonance spectroscopy of the central nervous system. Oak Brook, IL: ACR-ASNR; 2010.
Potgieser AR, Wagemakers M. The role of diffusion tensor imaging in brain tumor surgery: a review of the literature. Clin Neurol Neurosurg. 2014;124:51–8.
ACR-ASNR-SPR. ACR-ASNR-SPR practice guideline for the performance of functional magnetic resonance imaging (fMRI) of the brain. Oak Brook, IL: ACR-ASNR; 2012.
(NICE/SCIE) National Institute for Health and Care Excellence/Social Care Institute of Excellence. Dementia: supporting people with dementia and their careers in health and social care. Clinical guideline CG42. London: NICE/SCIE; 2016.
Martin-Macintosh EL, Broski SM, et al. Multimodality Imaging of neurodegenerative processes: part I, the basics and common dementias. AJR. 2016;207:871–82.
Duara R, Loewenstein DA, et al. Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology. 2008;71:1986–92.
Josephs KA. Frontotemporal lobar degeneration. Neurol Clin. 2007;25:683–96.
Shams S, Fallmar D, et al. MRI of the swallow tail sign: a useful marker in the diagnosis of Lewy body dementia? AJNR. 2017;38:1737–41.
(NICE/SCIE) National Institute for Health and Care Excellence/Social Care Institute of Excellence. Parkinson’s disease in adults. Clinical guideline NG71. London: NICE/SCIE; 2017.
Seppi K, Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am. 2010;20:29–55.
Broski SM, Hunt C, et al. Structural and functional imaging in Parkinsonian syndromes. Radiographics. 2014;34:1273–92.
(NICE/SCIE) National Institute for Health and Care Excellence/Social Care Institute of Excellence. Epilepsy: diagnosis and management. Clinical guideline CG137. London: NICE/SCIE; 2016.
Téllez-Zenteno JF, Hernandez Ronquillo A, et al. Surgical outcomes in lesional and non-lesional epilepsy: a systematic review and meta-analysis. Epilepsy Res. 2010;89:310–8.
Friedman E. Epilepsy imaging in adults: getting it right. AJNR. 2014;203:1093–103.
Saini J, Kesavadas C, et al. Susceptibility weighted imaging in the diagnostic evaluation of patients with intractable epilepsy. Epilepsia. 2009;50:1462–73.
Haque S, Law M, et al. Imaging of lymphoma of the central nervous system, spine and orbit. Radiol Clin N Am. 2008;46:339–61.
Akter M, Hirai T, et al. Diffusion-weighted imaging of primary brain lymphomas: effect of ADC value and signal intensity of T2-weighted imaging. Comput Med Imag Graph. 2008;32:539–43.
Nandu H, Wen PY, et al. Imaging in neuro-oncology. Ther Adv Neurol Dis. 2018;11:1–19.
Lee EJ, terBrugge K, et al. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. AJR. 2011;196:71–6.
Okada H, Weller M, et al. Immunotherapy response assessment in neurooncology: a report of the RANO working group. Lancet Oncol. 2015;16:e534–42.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ferrazzoli, V., Mankad, K. (2019). Radiological Imaging in Brain Disorders: An Overview. In: Fraioli, F. (eds) PET/CT in Brain Disorders. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-030-01523-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-01523-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01522-0
Online ISBN: 978-3-030-01523-7
eBook Packages: MedicineMedicine (R0)